Stay updated with breaking news from Combined Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from EQS-News: CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
Issuer: CureVac / Key word: Study CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza ; Development in Collaboration with GSK 24.04.2024 / 13:03...
Issuer: CureVac / Key word(s): Study CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Develop...
Issuer: CureVac / Key word(s): Study08.05.2023 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Announces Dosing of First Participant in Combined Phase 1/2 Study of Multivalent, Modified Influenza Vaccine Candidates Developed in Collaboration with GSK Initial Phase...
03.03.2022 - Multiple data readouts expected in 2022, including updates for all three clinical programs Ends 2021 with cash position of $219.6 million that is expected to fund operations into first quarter of 2024 BELTSVILLE, Md., March 03, 2022 (GLOBE ...